Replies to post #468323 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

My biggest concern is they say data is great but due to complexities of trial, they need to redo phase 3.

Yup, that's my highest risk.

Company would survive but shareholders would get fleeced by the necessary RS after this. No chance of recovering your investment, even after a successful trial down the road.

[JimSmith111]

Somebody needs a visit from The Shadow - are you sure this is a realistic possibility? My gosh how much egg would LL voluntarily put on her face?

My guess - not much.

[barnstormer]

You're concerned that after a self-imposed "quiet period" lasting over a year that they would issue a PR highlighting a presentation by the lead researcher (LL) at a major event, only to say they're going to have to redo phase? Really? You really think they would be that inept and LL would risk any damage to her reputation? Seriously?

[hoffmann6383]

I couldn't tell based on all the far flung criminal conspiracies you pushed each and every day. ;)

have a good one Bobby

- TS

[Maverick0408]

I think we will be fine. We know UK and EU has accepted new end points. FDA does not want to be left behind when the scientific and medical community worldwide clearly sees the benefit of this therapy, especially for an unmet need.

If the warrant holders were selling, we would have seen a big drop in SP. This is likely manipulation by MMs.

I think we should relax and give LP until the end of the week to show us what tricks she may have up her sleeve. If she doesn’t produce by the end of the day Thursday and rather gives all sort of BS like journal embargo, etc then it’s time to get out! I don’t think this is likely though. They have planned this carefully over the last 19 months!